ANI PHARMACEUTICALS, INC Inventory, Raw Materials, Gross
ANI PHARMACEUTICALS, INC (ANIP) had Inventory, Raw Materials, Gross of $77.77 million as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Notes › Inventory › Inventory, Gross
us-gaap:InventoryRawMaterials · last filed 2026-08-07
- 2026-06-30: Inventory, Raw Materials, Gross $77.77M.
- 2026-03-31: Inventory, Raw Materials, Gross $83.33M.
- 2025-12-31: Inventory, Raw Materials, Gross $84.11M; Inventory, Raw Materials, Gross as first filed $74.36M.
- 2025-09-30: Inventory, Raw Materials, Gross $68.65M.
| Period end | Inventory, Raw Materials, Gross | Inventory, Raw Materials, Gross as first filed |
|---|---|---|
| 2026-06-30 | $77.77M 10-Q · filed 2026-08-07 | |
| 2026-03-31 | $83.33M 10-Q · filed 2026-05-08 | |
| 2025-12-31 | $84.11M 10-Q · filed 2026-08-07 | $74.36M 10-K · filed 2026-02-27 |
| 2025-09-30 | $68.65M 10-Q · filed 2025-11-07 | |
| 2025-06-30 | $63.85M 10-Q · filed 2025-08-08 | |
| 2025-03-31 | $60.83M 10-Q · filed 2025-05-09 | |
| 2024-12-31 | $67.17M 10-K · filed 2026-02-27 | |
| 2024-09-30 | $67.23M 10-Q · filed 2024-11-08 | |
| 2024-06-30 | $62.58M 10-Q · filed 2024-08-06 | |
| 2024-03-31 | $55.12M 10-Q · filed 2024-05-10 | |
| 2023-12-31 | $62.24M 10-K · filed 2025-02-28 | |
| 2023-09-30 | $58.75M 10-Q · filed 2023-11-08 | |
| 2023-06-30 | $67.02M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $69.53M 10-Q · filed 2023-05-08 | |
| 2022-12-31 | $67.73M 10-K · filed 2024-02-29 | $70.50M 10-K · filed 2023-03-09 |
| 2022-09-30 | $62.42M 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $59.18M 10-Q · filed 2022-08-08 | |
| 2022-03-31 | $52.82M 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $51.35M 10-K · filed 2023-03-09 | |
| 2021-09-30 | $33.99M 10-Q · filed 2021-11-01 | |
| 2021-06-30 | $38.88M 10-Q · filed 2021-08-06 | |
| 2021-03-31 | $39.75M 10-Q · filed 2021-05-07 | |
| 2020-12-31 | $41.59M 10-K · filed 2022-03-15 | |
| 2020-09-30 | $43.01M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $37.70M 10-Q · filed 2020-08-06 | |
| 2020-03-31 | $35.34M 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $34.88M 10-K · filed 2021-03-11 | |
| 2019-09-30 | $33.06M 10-Q · filed 2019-11-06 | |
| 2019-06-30 | $36.35M 10-Q · filed 2019-08-07 | |
| 2019-03-31 | $29.75M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $27.67M 10-K · filed 2020-02-27 | |
| 2018-09-30 | $26.65M 10-Q · filed 2018-11-06 | |
| 2018-06-30 | $25.77M 10-Q · filed 2018-08-07 | |
| 2018-03-31 | $23.52M 10-Q · filed 2018-05-08 | |
| 2017-12-31 | $22.14M 10-K · filed 2019-02-27 | |
| 2017-09-30 | $17.81M 10-Q · filed 2017-11-02 | |
| 2017-06-30 | $17.18M 10-Q · filed 2017-08-03 | |
| 2017-03-31 | $17.48M 10-Q · filed 2017-05-04 | |
| 2016-12-31 | $14.14M 10-K · filed 2018-02-27 | |
| 2016-09-30 | $14.54M 10-Q · filed 2016-11-03 | |
| 2016-06-30 | $12.58M 10-Q · filed 2016-08-04 | |
| 2016-03-31 | $10.65M 10-Q · filed 2016-05-05 | |
| 2015-12-31 | $10.19M 10-K · filed 2017-03-02 | |
| 2015-09-30 | $10.56M 10-Q · filed 2015-11-03 | |
| 2015-06-30 | $9.95M 10-Q · filed 2015-08-04 | |
| 2015-03-31 | $7.97M 10-Q · filed 2015-05-05 | |
| 2014-12-31 | $5.06M 10-K · filed 2016-02-23 | |
| 2014-09-30 | $4.46M 10-Q · filed 2014-11-10 | |
| 2014-06-30 | $3.45M 10-Q · filed 2014-08-07 | |
| 2014-03-31 | $3.48M 10-Q · filed 2014-05-12 | |
| 2013-12-31 | $1.48M 10-K · filed 2015-02-23 | |
| 2013-09-30 | $1.41M 10-Q · filed 2013-11-07 | |
| 2013-06-30 | $1.31M 10-Q · filed 2013-08-09 | |
| 2012-12-31 | $975.00K 10-K · filed 2014-02-28 | $974.97K 10-Q · filed 2013-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |